Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial

Morimoto, T; Sakuma, I; Sakuma, M; Tokushige, A; Natsuaki, M; Asahi, T; Shimabukuro, M; Nomiyama, T; Arasaki, O; Node, K; Ueda, S

Morimoto, T (reprint author), Hyogo Coll Med, Dept Clin Epidemiol, 1-1 Mukogawa, Nishinomiya, Hyogo 6638501, Japan.

SCIENTIFIC REPORTS, 2019; 9 ():

Abstract

Additional reductions in low-density lipoprotein-cholesterol (LDL-C) via antidiabetic therapies should be considered in statin-using patients with sub......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索